The information contained within this
announcement is deemed to constitute inside information as
stipulated under the retained EU law version of the Market Abuse
Regulation (EU) No. 596/2014 (the "UK MAR") which is part
of UK law by virtue of the European
Union (Withdrawal) Act 2018. The information is disclosed in
accordance with the Company's obligations under Article 17 of
the UK MAR. Upon the publication of this announcement,
this inside information is now considered to be in the public
domain.
16 December 2024
Eden
Research
("Eden"
or "the Company")
Appointment of distributor in
Austria
Eden Research plc (AIM: EDEN), a
leader in sustainable biopesticide and biocontrol products, is
pleased to announce it has signed an agreement with Sumi Agro
Europe for the distribution of its flagship fungicide, Mevalone®,
in Austria.
Sumi Agro Europe's appointment as
Eden's exclusive distributor expands the companies' partnership
across the Central European region, with Sumi Agro Europe already
acting as the exclusive distributor for Mevalone in a number of
countries, including Poland and Germany. Application for Mevalone's
use has been submitted with the local regulators, and a decision is
expected in 2025. Authorisation will initially apply to grapes and
apples.
Renowned for its dry and delicate
Grüner Veltliner grape variety, Austria is amongst Central Europe's
largest wine markets, with over 45,000 hectares of vineyards across
the country. Austria is a leader in not only conventional
production but also organic and biodynamic viticulture. Over 15% of
vineyards are certified organic, reflecting the country's
commitment to sustainability. Additionally, strict wine regulations
ensure high-quality production, with classifications like DAC
(Districtus Austriae Controllatus) defining regional
typicity. As a biopesticide derived on plant-based chemistry,
Mevalone is exempt from such residue limits, providing vineyard
managers and grape growers with greater flexibility.
As the third largest producer of
apples across Central Europe, behind Poland and Germany, apples
also make up a sizable portion of Austria's overall agricultural
output, with apple orchards spanning approximately 15,000 hectares.
Mevalone has been shown to extend the life of apples in the supply
chain, minimising food waste between farm to consumer.
Sean
Smith, Chief Executive Officer of Eden Research plc,
commented:
"As we prepare for a full launch of
our product across Austria, we are delighted to expand our
partnership with Sumi Agro who have been a trusted and reliable
partner across the Central European region, backed by a strong
network of customers. As with other neighbouring territories,
Mevalone's upcoming introduction to the Austrian market comes at a
time when regulators are taking increasing action against
conventional products, leaving local farmers with few alternatives.
We believe Mevalone not only provides a direct alternative to those
farmers needing to address these market challenges but it is also
aligned with the regulator's objectives to foster a more
sustainable agricultural future."
Nicola De Tomasso, Business Development Manager in Sumi Agro
Europe, commented:
"Eden's mission to bring sustainable
agriculture to the industry through plant-derived chemistry has
resonated incredibly well with our customers across Germany and
Poland. Extending our partnership with the company into Austria has
been an obvious decision considering Mevalone's recent success in
the region, which we expect to continue growing from strength to
strength. We look forward to cooperating closely with Eden towards
achieving full authorisation for Mevalone and, upon its receipt,
working swiftly to distribute the product across our network of
Austrian vineyards and orchards."
- ENDS
-
For further information
contact:
Eden
Research plc
|
www.edenresearch.com
|
Sean Smith
Alex Abrey
|
01285 359
555
|
|
|
Cavendish Capital Markets Limited (Nominated advisor and
broker)
|
|
Giles Balleny / George
Lawson (Corporate Finance)
Charlie Combe (Broking)
Michael Johnson (Sales)
|
020 7397
8900
|
|
|
Hawthorn Advisors (Financial PR)
|
|
Victoria Ainsworth
|
eden@hawthornadvisors.com
|
Notes to Editors:
Eden
Research is the
only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative
biopesticide products and natural microencapsulation technologies
to the global crop protection, animal health and consumer products
industries.
Eden's products are formulated with
terpene active ingredients, based on natural plant defence
metabolites. To date, they have been primarily used on high-value
fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional
pesticides. Eden has three products currently on the
market:
Based on plant-derived active
ingredients, Mevalone® is a foliar biofungicide which
initially targets a key disease affecting grapes and other
high-value fruit and vegetable crops. It is a useful
tool in crop defence programmes and is aligned with the
requirements of integrated pest management programmes. It is
approved for sale in a number of key countries whilst Eden and its
partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.
Cedroz™ is a
bionematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and
vegetable crops globally. Cedroz is registered for sale on
two continents and Eden's commercial collaborator, Eastman
Chemical, is pursuing registration and commercialisation of this
important new product in numerous countries globally.
Eden's seed treatment
product, EcovelexÔ was developed to safely tackle crop destruction caused
by birds - a major cause of losses in maize and other
crops. Ecovelex works by creating an unpleasant taste or odour
that repels birds, leaving the seeds safely intact and the birds
unaffected and free to find alternative food sources. The
product is based on Eden's plant-derived chemistry, registered in
the EU, U.S. and elsewhere, and formulated using Eden's Sustaine®
microencapsulation system.
Eden's Sustaine® encapsulation
technology is used to harness the biocidal efficacy of naturally
occurring chemicals produced by plants (terpenes) and can also be
used with both natural and synthetic compounds to enhance their
performance and ease-of-use. Sustaine microcapsules are
naturally-derived, plastic-free, biodegradable micro-spheres
derived from yeast. It is one of the only viable, proven and
immediately registerable solutions to the microplastics problem in
formulations requiring encapsulation.
Eden was admitted to trading on AIM
on 11 May 2012 and trades under the symbol EDEN. It was
awarded the London Stock Exchange Green Economy Mark in January
2021, which recognises London-listed companies that derive
over 50% of their total annual revenue from products and services
that contribute to the global green economy. Eden derives 100% of
its total annual revenues from sustainable products and
services.
For more information about Eden,
please visit: www.edenresearch.com.